Increased urinary cystatin C level is associated with interstitial fibrosis and tubular atrophy in kidney allograft recipients

Clinical Biochemistry

Volumn 48, Issue 7-8, 2015, Pages 546-549

  Mendes, Maria de Fátima Castro ^a   Salgado, João Victor ^a   de Ribamar Lima, José ^a   Ferreira, Teresa Cristina Alves ^a   Silva, Gyl Eanes Barros ^a   Filho, Natalino Salgado ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

Cystatin c; Interstitial fibrosis tubular atrophy; Kidney allograft; Kidney transplantation; Renal biopsy; Urinary biomarkers

Indexed keywords

CREATININE; CYSTATIN C; SODIUM;

ADULT; ALLOGRAFT; BLOOD; FEMALE; FIBROSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; URINE;

ADULT; ALLOGRAFTS; CREATININE; CYSTATIN C; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SODIUM;

EID: 84937760352     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.02.008     Document Type: Article

References (21)

1. Lima J.R., Salgado J.V., Ferreira T.C., Oliveira M.I., Santos A.M., Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras 2011, 57:347-352.
2. Oliveira M.I., Santos A.M., Salgado Filho N. Survival analysis and associated factors to mortality of renal transplant recipients in a University Hospital in Maranhao. J Bras Nefrol 2012, 34:216-225.
3. Galichon P., Xu-Dubois Y.C., Finianos S., Hertig A., Rondeau E. Clinical and histological predictors of long-term kidney graft survival. Nephrol Dial Transplant 2013, 28:1362-1370.
4. Krieger N.R., Becker B.N., Heisey D.M., Voss B.J., D'Alessandro A.M., Becker Y.T., et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003, 75:1677-1682.
5. Alachkar N., Rabb H., Jaar B.G. Urinary biomarkers in acute kidney transplant dysfunction. Nephron Clin Pract 2011, 118:c173-c181. [discussion c81].
6. Camara N.O., Silva M.S., Nishida S., Pereira A.B., Pacheco-Silva A. Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival. Transplantation 2004, 78:269-275.
7. Amer H., Lieske J.C., Rule A.D., Kremers W.K., Larson T.S., Franco Palacios C.R., et al. Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant 2013, 13:676-684.
8. Hall I.E., Koyner J.L., Doshi M.D., Marcus R.J., Parikh C.R. Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation. Am J Nephrol 2011, 33:407-413.
9. Salgado J.V., Neves F.A., Bastos M.G., Franca A.K., Brito D.J., Santos E.M., et al. Monitoring renal function: measured and estimated glomerular filtration rates - a review. Braz J Med Biol Res 2010, 43:528-536.
10. Uchida K., Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002, 323:121-128.
11. Herget-Rosenthal S., Poppen D., Husing J., Marggraf G., Pietruck F., Jakob H.G., et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004, 50:552-558.
12. Conti M., Zater M., Lallali K., Durrbach A., Moutereau S., Manivet P., et al. Absence of circadian variations in urine cystatin C allows its use on urinary samples. Clin Chem 2005, 51:272-273.
13. Conti M., Moutereau S., Zater M., Lallali K., Durrbach A., Manivet P., et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 2006, 44:288-291.
14. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff '05 Meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7:518-526.
15. Inker L.A., Schmid C.H., Tighiouart H., Eckfeldt J.H., Feldman H.I., Greene T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012, 367:20-29.
16. Ortiz F., Harmoinen A., Paavonen T., Koskinen P., Gronhagen-Riska C., Honkanen E. Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?. Clin Nephrol 2008, 70:18-25.
17. Tomino Y., Suzuki S., Gohda T., Kobayashi M., Horikoshi S., Imai H., et al. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 2001, 15:25-29.
18. Proletov I., Saganova E.S., Galkina O.V., Zubina I.M., Bogdanova E.O., Sipovskii V.G., et al. Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies. Ter Arkh 2013, 85:10-16.
19. Park M.Y., Choi S.J., Kim J.K., Hwang S.D., Lee Y.W. Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury. Nephrology 2013, 18:256-262.
20. Makris K., Nikolaki E., Nanopoulos K., Pirgakis K.M., Maltezos C.K. Measurement of cystatin C in human urine by particle-enhanced turbidimetric immunoassay on an automated biochemistry analyzer. Clin Biochem 2013, 46:1128-1130.
21. Conti M., Moutereau S., Esmilaire L., Desbene C., Lallali K., Devanlay M., et al. Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. Clin Chem Lab Med 2009, 47:1553-1556.